Navigation Links
Ganeden Biotech Receives Frost & Sullivan 'Probiotics Product Innovation' Award
Date:12/16/2008

Unique probiotic strain, GanedenBC30, recognized for superior survivability and for opening new food and beverage product categories

CLEVELAND, Dec. 16 /PRNewswire/ -- Frost & Sullivan, the international growth consulting company, named Ganeden Biotech Inc. the recipient of its 2008 North American Food and Beverage Probiotics Product Innovation Award. The award recognizes Ganeden Biotech's innovative probiotic strain, GanedenBC30(TM), for opening new development initiatives in food and beverage product categories.

Frost & Sullivan's prestigious Probiotics Product Innovation award was granted to Ganeden Biotech for the advancement of the patented technology driving GanedenBC30. GanedenBC30 is able to survive harsh manufacturing processes, such as baking and freezing, as well as the acidic environment of the digestive tract better than other commercially available probiotic strains. This probiotic bacteria is more robust than traditional probiotic strains because it is protected by a spore, which is analogous to a seed and accounts for the strain's superior viability. The spore protects the cell's genetic material from the heat and pressure of manufacturing processes, challenges of shelf life and the acid and bile to which it is exposed to during digestive transit. The viable spore is then able to grow and multiply into new cells in the small and large intestines.

"The introduction of GanedenBC30 has certainly expanded the application of probiotics into product areas that were previously unavailable within food and beverage markets," said Dr. Deborah Cross, Industry Analyst at Frost & Sullivan. "The number of products available has already been enhanced substantially in previously undeveloped sectors such as bakery and snacks." GanedenBC30 has many times the rate of survival of the probiotic strains typically found in most probiotic-enhanced yogurts and can survive baking temperatures above 350 degrees Fahrenheit, making it particularly effective and robust.

In 2008, Ganeden Biotech teamed up with a number of food and beverage manufacturers to develop a wide variety of probiotics-enhanced products, including non-refrigerated nutrition bars, condensed soups, muffins and frozen yogurt. GanedenBC30 is also available in the over-the-counter probiotic products under the Digestive Advantage and Sustenex brands.

"We are grateful for Frost & Sullivan's recognition of our hard work in developing a powerful probiotic strain that can provide consumers with a range of health benefits," said Ganeden Biotech CEO Andrew Lefkowitz. "We look forward to continuing to work with food and beverage manufactures in developing innovative probiotic-enhanced products to help consumers lead happier and healthier lives."

About Ganeden Biotech

Founded in 1996, Ganeden Biotech Inc. is based in Cleveland, Ohio, and is the largest seller of over-the-counter probiotics in the U.S. through its Digestive Advantage(R) and Sustenex(TM) brands. It also licenses its patented probiotic bacteria, GanedenBC30(TM), for use in commercial food and beverage applications, medical foods, nutraceuticals and in animal health industries. GanedenBC30 is self-affirmed GRAS (Generally Recognized As Safe) by an independent panel of experts assembled to assess its safety in use as a food ingredient. For more information about licensing opportunities visit ganedenlabs.com and for probiotic supplement information visit digestiveadvantage.com or sustenex.com.

About Frost & Sullivan

Frost & Sullivan, the Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnerships, visit http://www.frost.com.


'/>"/>
SOURCE Ganeden Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Isabellas Healthy Bakery Unveils Activate - A New Probiotic Muffin Fortified with GanedenBC30 Probiotic
2. Ganeden Biotech Takes Sustenex(TM) National with GanedenBC30 Probiotic
3. Ganeden Biotech Obtains Self-Affirmed GRAS Status for Probiotic Ingredient, GanedenBC30 (Bacillus coagulans GBI-30, 6086)
4. Oncolytics Biotech Inc.s REOLYSIN(R) Exceeds Primary Statistical Endpoint in U.S. Phase 2 Sarcoma Study
5. Biotechnology Value Fund Delivers Letter to Board of Directors of Avigen, Inc.
6. Axial Biotech Launches Genetic Test for Adolescent Idiopathic Scoliosis (AIS)
7. Investor Group Reconfigures Proposed Slate of Replacement Directors for Trinity Biotech
8. The MedZilla Report: October 2008 Employment Outlook for Biotech/Pharma/Health
9. Ernst & Young Benchmarks Danish Biotech Pipeline Third in Europe
10. Micromet Added to NASDAQ Biotechnology Index
11. Biotech Endorsement Insurance Discount Expanded to Nebraska, Kansas Growers Planting Corn with HERCULEX XTRA Traits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... Infectex Ltd., a Russian portfolio company of Maxwell Biotech Venture Fund (MBVF), ... the standard drug therapy regimen in patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). SQ109 is ... ) and the US National Institutes of Health. ... ... ...
(Date:3/27/2017)... NC (PRWEB) , ... March 27, 2017 , ... ... Clinical Trial Collaborations (CTC) conference presented by The Conference Forum in Boston on ... way they collaborate to drive improved clinical trial outcomes and bring them closer to ...
(Date:3/27/2017)... 2017 Neurotrope, Inc. (OTCQB: NTRP),  a ... diseases, including Alzheimer,s disease, today announced that it ... the Company,s common stock on the NASDAQ Capital ... Market, a unit of the NASDAQ OMX Group. ... Opening Bell at the NASDAQ MarketSite in Times ...
(Date:3/24/2017)... Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: SVA), ... , today announced that its board of directors has amended its ... from March 27, 2017 to March 27, 2018. The amendment was not ... Biotech Ltd. ... Sinovac Biotech Ltd. is a China -based ...
Breaking Biology Technology:
(Date:3/16/2017)... 16, 2017 CeBIT 2017 - Against identity fraud with DERMALOG solutions ... ... Used combined in one project, multi-biometric solutions provide a crucial contribution against ... Used combined in one project, ... ...
(Date:3/9/2017)... FRANCISCO and MOUNTAIN VIEW, Calif. ... , "Eating Well Made Simple," and 23andMe , ... help guide better food choices.  Zipongo can now provide ... their food preferences, health goals and biometrics, but also ... certain food choices. Zipongo,s personalized food decision ...
(Date:3/6/2017)... 2017 Mintigo , the leader ... Predictive Sales Coach TM , its new artificial ... into Salesforce. This unique AI application will allow ... with deep knowledge of their customers and prospects ... Predictive Sales Coach extends Mintigo,s existing customer success ...
Breaking Biology News(10 mins):